MPT0B640
JO201901-02
Phase 1 small_molecule terminated
Quick answer
MPT0B640 for Covid19 is a Phase 1 program (small_molecule) at INTENSITY THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTENSITY THERAPEUTICS, INC.
- Indication
- Covid19
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated